Cargando…
A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1
INTRODUCTION: Niemann-Pick C (NPC) is an autosomal recessive disease due to defective NPC1 or NPC2 proteins resulting in endo-lysosomal storage of unesterified cholesterol in the central nervous system and liver. Acute liver disease in the newborn period may be self-limited or fatal. 2-hydroxypropyl...
Autores principales: | Reynolds, Margaret, Linneman, Laura A., Luna, Sofia, Warner, Barbara B., Turmelle, Yumirle P., Kulkarni, Sakil S., Jiang, Xuntian, Khanna, Geetika, Shinawi, Marwan, Porter, Forbes D., Ory, Daniel S., Cole, F. Sessions, Dickson, Patricia I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170172/ https://www.ncbi.nlm.nih.gov/pubmed/34113546 http://dx.doi.org/10.1016/j.ymgmr.2021.100772 |
Ejemplares similares
-
Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
por: Yergey, Alfred L., et al.
Publicado: (2017) -
Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
por: Yergey, Alfred L., et al.
Publicado: (2018) -
Towards a New Diagnostic Standard for Niemann–Pick C Disease
por: Jiang, Xuntian, et al.
Publicado: (2016) -
Effects of intracerebroventricular administration of 2-hydroxypropyl-β-cyclodextrin in a patient with Niemann–Pick Type C disease
por: Matsuo, Muneaki, et al.
Publicado: (2014) -
2-Hydroxypropyl-β-cyclodextrins and the Blood-Brain Barrier: Considerations for Niemann-Pick Disease Type C1
por: Calias, Pericles
Publicado: (2017)